Thromboelastography (TEG) is a method of testing the efficiency of blood coagulation. It is a test mainly used in surgery and anesthesiology, although increasingly used in resuscitations in Emergency Departments, intensive care units, and labor and delivery suites. More common tests of blood coagulation include prothrombin time (PT) and partial thromboplastin time (aPTT) which measure coagulation factor function, but TEG also can assess platelet function, clot strength, and fibrinolysis which these other tests cannot. Thromboelastography Analyzer provides rapid, comprehensive and accurate identification of an individual's hemostasis condition in a laboratory or point-of-care setting.
This report contains market size and forecasts of Thromboelastography Analyzer Systems in global, including the following market information:
Global Thromboelastography Analyzer Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Thromboelastography Analyzer Systems Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Thromboelastography Analyzer Systems companies in 2021 (%)
The global Thromboelastography Analyzer Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single and Double Channel Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Thromboelastography Analyzer Systems include Haemonetics, WerfenLife, Framar Hemologix srl, Sienco, Lepu Technology, Improve Medical, Medcaptain, Render and Chongqing Dingrun, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thromboelastography Analyzer Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thromboelastography Analyzer Systems Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Thromboelastography Analyzer Systems Market Segment Percentages, by Type, 2021 (%)
Single and Double Channel
Four Channels
Others
Global Thromboelastography Analyzer Systems Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Thromboelastography Analyzer Systems Market Segment Percentages, by Application, 2021 (%)
Hospital
Maternal and Child Health Service
Laboratory
Others
Global Thromboelastography Analyzer Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Thromboelastography Analyzer Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thromboelastography Analyzer Systems revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Thromboelastography Analyzer Systems revenues share in global market, 2021 (%)
Key companies Thromboelastography Analyzer Systems sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Thromboelastography Analyzer Systems sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Haemonetics
WerfenLife
Framar Hemologix srl
Sienco
Lepu Technology
Improve Medical
Medcaptain
Render
Chongqing Dingrun
Zhejiang Shengyu
Bio-zircon